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Abstract
Several Gram-negative pathogenic bacteria have evolved a complex protein secretion
system termed the Type Three Secretion System (TTSS) to deliver bacterial effector
proteins into host-cells that then modulate host-cellular functions. These bacterial devices
are evolutionarily related to the flagellar apparatus. Although the TTSSs are substantially
conserved among different species, the effector molecules they deliver are speciesunique. There exist three human pathogenic Yersiniae. Yersinia enterocolitica and
Yersinia pseudotuberculosis cause self-limiting gastro-enteric diseases and infect
mesenteric lymph nodes, while Yersinia pestis is transmitted by fleas and can be
aerosolized, causing the lethal disease known as plague (also known as Black Death).
The TTSS is composed of over 20 proteins making up the injectisome (inserted directly
into the host-cell), in addition to translocator, regulator, and modulator proteins, as well
as chaperones for several effector proteins. Today, plague is still a health concern due to
the ability of Y. pestis to be aerosolized. No effective vaccines are currently available to
the public. However, research is being implemented to create a vaccine that can be
widely used. The purpose of this paper is to update the state of the Yersiniae TTSSs by
providing a review of recently published primary articles.
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Yersiniae Virulence Factors: Type III Secretion System
Of three human pathogenic Yersiniae, Y. enterocolitica and Y. pseudotuberculosis
enter their hosts via the oral-fecal route of infection and are self-limiting enteric
pathogens, which infect the mesenteric lymph nodes (14). In contrast, Y. pestis is
transmitted by fleabite or via the aerosol route and infect regional lymph nodes or lungs
leading to the lethal disease known as plague (14).
Y. pestis is thought to have evolved from Y. pseudotuberculosis relatively recently
(27). Molecular clock estimates, based on mutational differences, place Y. pestis’
emergence as recently as 9,000 to 40,000 years ago. In comparing Y. pestis and Y.
pseudotuberculosis, Y. pestis has two additional plasmids and has lost some chromosomal
genes by deletion or inactivation. These differences enable Y. pestis to survive in its
vector, the flea, and account for Y. pestis’ unique route of infection (27).
Common to all three pathogenic Yersiniae is the presence of type III secretion
system (TTSS) (14, 8). The TTSS is encoded on an approximately 70-kb virulence
plasmid termed pYVE or pCD1 (8). The TTSS functions to inject bacterial effector
proteins directly into the host-cell cytoplasm and has thus been referred to as an
injectisome (8). This system can also be found in several Gram-negative bacteria, and
although the systems are highly conserved, the effector molecules delivered into targeted
host-cells are unique for each bacterial species (8).
The TTSS functions by means of a secretion apparatus composed of 20-25
different Yersinia secretion proteins (Yscs) (8, 18, 23). In fact, all 25 Yscs are required
for a fully functioning secretion apparatus (14). It is believed that these injectisomes are
environmental sensory receptors that sense the 37 C, low intracellular calcium
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concentration of the host-cell, which induces the expression of the effector proteins from
TTSS operons. This response is known as the low-calcium response (14). Interestingly,
Ysc proteins that comprise the TTSS’s injectisome are homologous to flagellar proteins
and therefore are thought to have evolved divergently from the flagellar proteins (Figure
1).
Regulation and function of the Yersiniae TTSSs have been extensively studied. A
detailed description of the TTSS and the Gram-negative bacteria who posses it was
published in 1998 by Hueck (14). A more recent description of the Yersinia Outer
Proteins (Yops) was published in 2005 by Viboud and Bliska (36). The aim of this paper
is to update the state of the Yersiniae TTSSs.
There are 13 Yops, which are secreted by the TTSS injectisome. These proteins
are grouped roughly into the following categories: (i) translocatory proteins involved in
the translocation process, (ii) regulatory proteins, and (iii) effector proteins with direct
anti-host functions. Interestingly, three of the effector proteins with direct anti-host
functions, YopH, YpkA (YopO in Y. enterocolitica), and YopM, which are translocated
into the host cytoplasm, are homologous to eukaryotic proteins and are thought to have
been acquired from the eukaryotic host-cells. For example, YopH is a protein with
tyrosine phosphatase activity and is homologous to the eukaryotic protein tyrosine
phosphatase (PTPase) (11). The Yersiniae utilize YopH to dephosphorylate several
macrophage proteins, thereby evading phagocytosis (14).
Plague continues to be a determent to our society. Between 1987 and 2001, 36,
876 cases of plague with 2,847 deaths were reported to the World Health Organization
(WHO) (27). Closer to home, in 1992, there was an outbreak in which a plethora of
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chipmunks were found dead in the four corners region of the United States: New Mexico,
Arizona, Utah, and Colorado. Another reason the plague continues to be a health concern
is because of Y. pestis’ unique ability to be aerosolized (communicated via respiratory
droplets) and potentially be weaponized by bioterrorists (27). While much has been
accomplished in determining Y. pestis’ mechanism of action in causing plague, more still
needs to be discovered to produce an adequate vaccine.
At present, no effective plague vaccines are available. Those previously
developed and used in humans confer low levels of protection, have numerous side
effects, and require frequent boosting to develop immunity (27). However, LcrV is an
effector protein translocated along with other Yops by the TTSS and is now being
targeted as a vaccine candidate (26).
Injectisome: The TTSS needle
The TTSS employs a needle-like apparatus, termed the injectisome, to translocate
effector proteins directly into the cytosol of a targeted host-cell (8). The injectisome is
composed of about 25 Yscs and uses three translocator Yops, YopB, YopD and LcrV, to
form a pore in the host-cell for the translocation of the effector Yops across the target cell
membrane (8, 18, 23) (Refer to Yersinia outer proteins section below). Injectisomes
consist of a basal body spanning both the inner and outer bacterial membranes and a
needle (23).
Recently, many of the proteins that make up the injectisome have been shown to
be homologous to flagellar proteins (14). A possible explanation for the evolution of the
TTSS needle is that it divergently evolved from the basal body of the flagellar apparatus
(14). After its evolution, several Gram-negative bacteria could have acquired the system
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by horizontal genetic transfer. Although the secretion apparatus is highly conserved
among many Gram-negative bacteria, the effector molecules that they deliver are unique
to each bacterial species. Therefore, the needle complex may have divergently evolved
from the flagellar proteins, whereas the effector molecules were not.
A comparison of the flagellar protein FliN and injectisome protein Ysc Q showed
that FliN carries a carboxy-terminal domain of 60 amino acids that is homologous to a
respectively located domain in the members of the YscQ family (14). It was also shown
that FliF shares a domain with YscJ (14) (Figure 1).
Structural homologs suggest common evolutionary heritage.
(a). FliN_Y. pestis: 61-123
YscQ_Y. pestis: 236-298
FliN_Y. pestis
YscQ_Y. pestis

IPVKLSVELGRTKMT I KELLRLSQGSVVSLDGLAG EPLDI L I NGYLI AQ
LP V Q V S F E V G R Q I L D W H T L T S L E P G S L I D L T T P V D G E V R L L A N G R L L G H

FliN_Y pestis
YscQ_Y. pestis

GEVVVVADKYGVRI
GRLVE I QGR LGVR I

(b). FliF Y. pt:
YscJ Y. pt:

56-242
23-213

FliF Y. pt
YscJ Y. pt

LYSNLSDRDGGDI VTQ LTQLNI PY – RFADNGGA- - LL I PAEKVHETRL
LYTGI SQKEGNEMLAL LRQEGLSADKEP DKDGKIKLLVEE SDVAQAI D

FliF Y. pt
YscJ Y. pt

RLAQQGLP KGGAVGFE LLDQE KFGISQFSEQI - - - NYQRALEGELSRTI
I LKRK GYPHE SF S TLQDVFP KDGLISS PI EELARLNYAKAQE - - ISRTL

FliF Y. pt
YscJ Y. pt

GTLGPVLNVRVH LAMPKPSLFV REQK SP TASVTLALQPGRALD–DGQI
S EI DGVLVARVHVVL PEEQ–NNKGKKGVAASASVFI KHAADIQF DTYI

FliF Y. pt
YscJ Y. pt

NAIVYMVS SSVAGLPPGNVTVVDQTGRLLTQSDSAGRDLNASQLKFTS E
P QIKQL VNNSI EGLAYDRI SV I LVPSVDVRQSSHL PRNTS I LS IQ VSEE

Figure 1. The amino acid sequences for these proteins were obtained from the National Center for Biotechnology Information (NCBI)
database and compared using Basic Local Alignment Search Tool (BLAST) (7, 24). Dark blue indicates identities. Aqua indicates
amino acid similarities. (a)Analysis of FliN_Y. pestis flagellar motor switch protein and YscQ_Y. pestis Yop protein translocation
protein Q reveals 33% identity and 53% amino acid similarity. (b) Analysis of FliF_Y. pseudotuberculosis (Y. pt) flagellar motor
switch protein and YscJ_Y. pt Yop protein translocation protein Q reveals 23% identity and 46% amino acid similarity.

The end of the needle-like structure is made up of YscF, with YopN possibly
acting as a “plug”(33). The role of LcrV, YscF, and YopN in the formation of the pore
required by the injectisome to deliver the Yops in macrophages was tested by monitoring
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the release of the low-molecular-weight fluorescent dye BCECF (2′, 7′-bis- (2carboxyethyl)-5-(and-6)-carboxyfluorescein, acetoxymethyl ester, 623 Da) and of the
high-molecular-weight lactate dehydrogenase (LDH, 135 kDa). Bacteria producing
normal Ysc injectisomes, including the YscF needle but no translocators, did not form
pores, indicating that the needle is not sufficient by itself for pore formation. YopN might
form a link between the needle and the pore, guiding the effectors (18).
In a more recent study, it was found that the length of the injectisome is
genetically defined (2). The length of the needle is determined by YscP, which acts as a
molecular ruler (3). It is found that a minimal needle length was required for efficient
functioning of the Y. enterocolitica injectisome and the minimal needle length correlated
with the length of the major adhesin at the bacterial surface. The needle may be required
for triggering type III secretion, suggesting that needle length may have evolved to match
specific structures at both the bacterial and host-cell surfaces (22). YscP is also secreted
and was found to be required for Yop secretion by a systematic deletion analysis where
the specific region required for Yop secretion (between residues 405 and 500) was
accurately localized (2).
YscU, also a key component of the TTSS injectisome, undergoes auto-cleavage of
an N-terminal transmembrane domain and a long cytoplasmic C-terminal domain at a
NPTH site (32). A yscUN263A mutant makes needles without the LcrV tip complex,
essential to pore formation, and could not form translocation pores. The yscUN263A
mutant was also shown to export less amounts of YscP (the molecular ruler) and
consequently, made longer needles (32).
It was recently shown by electron microscopy (EM) analysis that the tip of
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needles that protrude from the bacterial surface contained a distinct structure caused by
LcrV bound to YscF (19). This unique localization of LcrV may explain its crucial role in
the translocation process and its efficacy as the main protective antigen against plague as
a vaccine candidate.
Yersinia Outer Proteins (Yops)
The Yops (toxic effector proteins) are encoded on several operons on the
virulence plasmid, and their expression is induced after a temperature shift from 25ºC to
37ºC, but at 27ºC in the presence of Ca2+ the system remains repressed (14, 41). Normal
growth of Y. pestis occurs at 25ºC to 27ºC (ambient temperature in flea gut). Eventually,
this temperature shift and contact with the mammalian cell (low calcium), leads to the
injection of the effector Yops from the bacterium into the host cell (41).
The Yops and other proteins secreted by Yersinia TTSS have been roughly
grouped into three categories: (i) translocatory proteins involved in the translocation
process and pore formation (YopB, YopD, and LcrV), (ii) proteins with direct anti-host
function and are translocated directly into the eukaryotic cytosol (YopH, YopM, YopE,
YopT, and YopJ) (16), and (iii) regulatory proteins, which mediate cell contact (YopN
and YopK) (14, 36) (Table 1).
Table 1. Yops and Other Proteins Secreted by Yersinia TTSS (13, 15, 33)
(i) Translocatory Proteins
YopB, YopD,
and LcrV
Are involved in the translocation process and pore formation
(ii) Proteins with direct anti-host function
YopH
Is a tyrosine protein phosphatase
YopM
Binds to -thrombin and blocks platelet activation
YopE
Directly polymerizes actin microfilaments
YopT
Is similar to YopE, YpkA/YopO are a serine/threonine protein kinases
Interferes with mammalian signaling pathways leading to the inhibition of phagocytosis,
YopJ
modulation of cytokine production, and induction of apoptosis
(iii) Regulator Proteins
YopN
Is surface exposed and involved in the low-calcium response
YopK
Seems to regulate the amount of effector Yops translocated
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YopB, YopD, and LcrV: Translocators
YopB and YopD are encoded in the lcrGVH-yopBD operon and their transcription
is induced by temperature (37 C) and millimolar concentrations of calcium (low-calcium
level, mimicking the internal host-cell environment) (14). It has been shown that YopB,
YopD (14), and LcrV are translocator proteins (33, 36). While these proteins are involved
in translocation, they are not actually translocated into the targeted host-cells. It has also
been suggested that these proteins make up the “translocation channel” in the host-cell
membrane (pore-formation) mainly because of their hydrophobic domains. However,
LcrV is the exception being a dimer in solution (36). The hydrophobic domains found in
YopB and YopD, suggested that they are probably transmembrane proteins. Interestingly,
YopB has been shown to independently disrupt artificial membranes, whereas YopD
cannot. YopB may achieve this by virtue of its two hydrophobic regions (residues 166 to
188 and 228 to 250). Recently, YopB’s ability to disrupt membrane was characterized by
altering the hydrophobic domains of YopB and then studying the change in the virulence
of the mutant strain containing the altered YopB protein (30).
In the aforementioned experiment, a helix-disrupting double consecutive proline
substitution in the center of the transmembrane domain of YopB proteins was
constructed. Either both hydrophobic domains were disrupted or only one hydrophobic
domain was disrupted. Y. pseudotuberculosis expressing the mutant proteins was used to
infect macrophage or epithelial cells. As it turned out, YopB with two disrupted domains
resulted in a non-functional protein, which was not secreted and the YopB with only one
disrupted hydrophobic domain had partially disrupted function. Ultimately, all three
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functions of YopB, translocation, pore formation, and signaling, require these
hydrophobic domains for insertion into the host-cell membrane (30).
The ability of YopB to insert into the host-cell membrane creating a channel
along YopD explains how the injectisome can maintain contact with the host-cell without
disrupting the integrity of the host-cell membrane. Furthermore, LcrV has also been
found to form channels in lipid bilayers and is believed to be part of the pore-formation
process making up the channel in which effector proteins are translocated (36). Also, it
has been found that the interaction of YopB with the host-cell triggers a proinflammatory signaling response in epithelial cells infected with y. pseudotuberculosis
(35). In fact, it was recently suggested that YopB could potentially be used to enhance the
immune response in eukaryotic cells (5).
YopH, YopO (YpkA), YopE, YopT, YopM, YopJ (YopP): Effectors
The most pronounced effects by the TTSS involves the action of several effector
Yops, such as YopE, YopH, YopO/YpkA, and YopT, which disrupt the target cellsignaling network and cytoskeleton rearrangement by targeting monomeric GTPases of
the Rho family (8, 41). YopH, YopO (YpkA in Y. pseudotuberculosis), YopE, YopM,
and YopJ (YopP in Y. enterocolitica) are directly translocated into the host-cell
cytoplasm by the TTSS. Interestingly, three of these effector proteins have been found to
be homologous to eukaryotic proteins (Figure 2).
YopH: A Tyrosine Protein Phosphatase
It is believed that several of these translocated effector Yops have been acquired
from the host itself. The yersiniae are able to use these homologous host proteins, to their
advantage. For example, YopH is a 468 amino acid long protein with tyrosine
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phosphatase and its carboxy terminal is homologous to the eukaryotic protein tyrosine
phosphatase (PTPase). In fact, YopH was shown to be the most active tyrosine
phosphatase known (11). The Yersiniae utilize YopH to dephosphorylate several
macrophage proteins contributing to their resistance to phagocytosis. One way in which
YopH has been shown to evade phagocytosis has been by inhibiting the invasin
interaction activated,

1 integrin pathway. YopH has two substrate recognition sites

(11). The presence of two substrate recognition sites is believed to be the evidence for
why this PTPase-like protein has evolved a highly complex mechanism to locate
substrates in the complex environment of the host-cell (36).
In a recent study, the factors important for growth during lung infection were
determined (9). Using a YopH mutant strain of Y. pseudotuberculosis, mice were infected
intra-nasally and growth was monitored in lungs and systemic tissues. As it turned out,
the YopH mutant failed to proliferate at wild-type levels four days after intranasal
inoculation. This study concluded that YopH, together with YopB, was essential for
development of a Y. pseudotuberculosis murine lung infection (9).
YpkA/YopO: A Serine/Threonine Protein Kinase
YpkA (YopO in Y. enterocolitica), approximately 730 amino acids, is transcribed
on an operon together with YopJ/YopP (14). YpkA has a serine/threonine kinase catalytic
site on the N-terminal half of the protein that is homologous to the eukaryotic
serine/threonine protein kinase (36). Like YopE and YopT, YpkA interacts with
RhoGTPase and thereby disrupts the actin cytoskeleton of cultured cells to prevent
phagocytosis (1). Because YpkA is weakly expressed, and the effector proteins, YopE
and YopH, mask its activity, a mutant with the deletion of these other two effector
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proteins has to be made in order to detect the activity of YpkA (14, 36, 39). It was
recently shown that a Y. pseudotuberculosis YpkA mutant with a deletion of its kinase
domain was greatly attenuated in a murine model of infection (39).
YopE: A GTPase Activating Protein (GAP)
YopE, 219 amino acids, is highly conserved amongst all three pathogenic Yersiniae
(14). YopE has been found to induce cytotoxic effects on host cells (4, 14, 36, 37). It was
proposed that YopE exhibits GTPase-activating protein (GAP) activity towards Rac1,
RhoA and Cdc42 and is essential for induction of the cytotoxic phenotype on HeLa cells
(rounding, etc.) and virulence (38). Although it had been demonstrated that the
cytotoxicity of YopE was due to its GAP activity toward the small GTP binding proteins,
RhoA, Rac-1, and Cdc42, in vitro (1) there was no formal evidence for a direct
interaction between YopE and any of these three RhoGTPases during an in-vivo
infection. In an effort to understand the functional role of YopE in vivo, its GAP activity
in infected eukaryotic cells was found to inactivate Rac1 as early as 5 minutes after
infection. On the other hand, RhoA was downregulated approximately 30 minutes post
infection and YopE had no apparent effect on the activation state of Cdc42 in infected
cells. This study demonstrated that Cdc42 is not an in vivo target for YopE, and that
YopE preferentially interacts with Rac1, and to a lesser extent with RhoA, within
targeted host-cells (4). Ultimately, the major function of YopE is thought to be its
contribution to the overall antiphagocytic activity of the Yersiniae TTSS (37).
YopT: Like YopE, also Downregulates Rho GTPase
YopT, 322 amino acids, is not expressed by sero-type strains of Y.
pseudotuberculosis and was therefore, the last effector protein identified in 2002 (8, 14).

https://nsuworks.nova.edu/mako/vol2/iss1/3

12

Blanco: Yersiniae Virulence Factors: Type III Secretion System
Yersinia Virulence Factors

13

In 2003, a yopE null (complete knock-out) Y. pseudotuberculosis mutant was found to be
much more attenuated than the Y. enterocolitica yopE mutant. This was most likely due
to Y. pseudotuberculosis lacking YopT. More importantly, RhoA modification was
shown to be strictly dependent on YopT without the need of any additional effector Yops
(18). More recently, YopE and YopT were shown to have some level of functional
redundancy by sharing overlapping virulence functions (37). Observations such as the
disruption of stress fibers, cell rounding, and inhibition of phagocytosis by YopE and
YopT led to this assumption (36).
In order to explore this assumption, the contributions of YopE and YopT to the
pathogenesis of Y. pseudotuberculosis were studied in a mouse infection and tissue
culture infection model. A YopE+T- strain and a YopE+T+ strain colonized spleens of
mice at similar levels after four days of oral infection. This observation suggests that
YopT is not required for virulence. In sharp contrast, spleen colonization by a YopE-Tstrain was significantly reduced. However, a YopE-T+ strain colonized spleens at levels
comparable to those of the YopE+T- strain. These data suggest that YopT can promote
virulence in the absence of YopE (37).
Furthermore, infection of HeLa cells with YopE-T-H-J- strain expressing either
YopE or YopT showed that YopE had a stronger antiphagocytic activity than YopT. This
study concluded that YopE is a potent inhibitor of infection-induced signaling cascades,
and YopT can only partially compensate for the loss of YopE (37), which explains why a
Y. enterocolitica yopE mutant, still experiences attenuated virulence.
YopM: Blocks Platelet Activation by Binding Thrombin
YopM, 376 amino acids, contains variable numbers of leucine rich repeat motifs
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and is the only Yersiniae TTSS effector Yop that does not encode an enzymatic activity
(36). YopM is homologous to the thrombin-binding domain of the

chain of human

platelet surface glycoprotein Ib (GPIb ). This protein is also homologous to a portion of
von Willebrand factor, which apart from its many functions, serves as a carrier of clotting
factor VIII (14) (Figure 2). Purified YopM was shown to bind thrombin and to inhibit
platelet aggregation in vitro (14). Although it is known that YopM plays an important
role in pathogenesis, the significance of thrombin binding for Y. pestis pathogenesis is not
clear (12). It is believed that YopM may compete with platelets for thrombin binding in
vivo and that the resulting prevention of blood clot formation could enhance the
dissemination of the bacteria throughout the body (14). Interestingly, YopM is
translocated into the cytosol of the host-cell and has been shown to localize to the nucleus
of the target cell (8), but it is not known how nuclear localization is related to the function
of YopM (36). The most recent data indicated that YopM targets the innate immune
system, as it was required for depletion of NK cells after intravenous infection of mice
with Y. pestis (15). Studies in which gene regulation by YopM was examined, gave
contradictory results as well as murine infection data (36). Figure 2 illustrates the
alignment of y. pestis’ YopM with human platelet glycoprotein Ib

(GP-Ib ).

Structural homologs suggest common evolutionary heritage.

43-132
(a). GP-Ip :
YopM_Y. pestis: 273-353
GP-Ip
YopM_Y. pestis

PDLPKDTT I LHLSENLLYTFSLAT LMPYTRLTQ LNLDRCELTKLQV
PE LPQS LTFLDVSENI - - -FSGL SE L P –PNLYYLNASS NEI RSL - -

GP-Ip
YopM_Y. pestis

D GT LPVLGTLD LSHNQLQSLPLLGQTLPALTVLDVSFNRLT SL P
C D LPP SL EELNVSNNKL I ELPALP - - - PRLERL I ASFNHLAEVP

Figure 2. The amino acid sequences for YopM and GPIb were obtained from the NCBI database and compared using BLAST (20).
Dark blue indicates identities. Aqua indicates amino acid similarities. (a)Analysis of human platelet glycoprotein Ib (GP- Ib ) and
Y. pestis Yop protein translocation protein M reveals 36% identity and 50% amino acid similarity.
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YopJ: A Cysteine Protease
YopJ (YopP in Y. enterocolitica), 264 amino acids, has been shown to induce
apoptosis in cultured murine macrophages (21). More recently, YopJ was found to cause
apoptosis by inhibiting the mitogen-activating protein kinase (MAPK) and nuclear factorB (NF- B) signaling pathways of the host-cell and blocking host proinflammatory
response by suppressing cytokine production (36), and interfering with ubiquitination
(tagging of proteins to be destroyed) (14). Yops counteract the MAPK and NF- B
signaling pathways of the host-cell by acting like a protease by means of binding and
blocking activation of the MAPK kinases and IKK (36, 42). Because NF- B promotes
cell survival, a recent study set out to determine whether inhibition of NF- B by YopJ
was enough to cause apoptosis (42). In order to accomplish this, macrophages expressing
NF- B inhibitors were infected with Y. pseudotuberculosis strains either expressing YopJ
or not. As it turned out, the Y. pseudotuberculosis strains expressing YopJ were more
effective in causing apoptosis than the strains that were not expressing YopJ, suggesting
that deactivation of both NF- B and MAPK pathways are necessary for Yersinia to cause
rapid apoptosis (42). YopJ has also been shown to be a deubiquitinating enzyme that
negatively regulates signaling by removing ubiquitin moieties from critical proteins. In
that regard, an in vitro assay demonstrated the deubiquitinating activity of purified YopJ
(43).
When YopP was directly coupled to YopJ, YopP was secreted more readily than
YopJ (41). Recently, a YopJ-deleted mutant strain of Y. pestis expressing YopP was
shown to provide a better apoptotic potential. In J774A.1 cells (a BALB/c murine
macrophage strain usually used for the production of monoclonal antibodies), RAW264.7
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cells (a murine macrophage strain that does not demonstrate the prostaglandin (PG)dependent autocrine regulation of tumor necrosis factor- (TNF-) secretion observed in
primary resident peritoneal macrophages (RPMs)), and primary murine macrophages,
better than even the most virulent strains of Y. pestis, EV76 and Kimberley 53 (35). It
has been proposed that perhaps Y. pestis expressed YopJ instead of YopP because in Y.
pestis’ early stages of infection it propagates in macrophages, and, therefore, it is more
advantageous for Y. pestis if these host-cells stay alive (41).
Still, the YopJ contribution to Y. pestis virulence is not clear. A recent study
concluded that YopJ suppresses tumor necrosis factor

(TNF- ) induction and

contributes to apoptosis of immune cells in the lymph node but is not a virulence factor in
a rat model of bubonic plague (17). Following intra-dermal infection with a fully virulent
Y. pestis strain or an isogenic yopJ mutant, it was determined that the deletion of yopJ
resulted in a two-fold decrease in the number of apoptotic immune cells in the bubo, a
swollen lymphnode, and a threefold increase in serum tumor necrosis factor

levels but

did not result in decreased virulence, systemic spread, or colonization levels in the spleen
and blood. Ultimately, the data suggest that YopJ is not essential for bubonic plague
pathogenesis, but rather, the effects of YopJ appear to overlap and augment the
immunomodulatory effects of other Y. pestis virulence factors (17).
More recently, YopJ was shown to exert its deleterious effect by catalyzing the
acetylation of two serine residues in the activation loop of the MAP kinase kinase,
MEK2, thereby preventing the phosphorylation of these serine residues required for
activation of MEK2 and downstream signal propagation. YopJ has been shown to
acetylate a threonine residue in the activation loop of both the
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NF- B pathway kinase, IKK (21). In addition, YopJ was found to not only inhibit
production of the inflammatory cytokine tumor necrosis factor

(TNF- ), but also was

found to inhibit the anti-inflammatory cytokine, interleukin-10 (IL-10) expression (6).
YopN and YopK: Regulator and Modulator
YopN and YopK are considered to be regulatory proteins because they mediate
cell contact and also have regulatory involvement (14). YopN is surface exposed and is
involved in the low-calcium response (14). TTSS secretion channels shut in the presence
of millimolar concentrations of Ca2+ found in mammalian blood (18). YopN mutants
were found to secrete large quantities of Yops even in the presence of Ca2+. For this
reason, YopN is thought to act as a “plug”. In the presence of an appropriate secretion
signal (low calcium concentration), YopN is secreted into the supernatant by the Yersinia
TTSS followed by the other effector Yops (18).
Unlike YopN, YopK seems to regulate the amount of effector Yops that are
translocated by acting as a modulator (13). YopK is encoded outside the lcrG-lcrV-sycDyopBD operon, and its expression is also regulated by temperature and calcium levels.
YopK is not translocated, but appears to be located in the vicinity of cell-associated
bacteria during the infection process (14). YopK was shown to play a modulatory role in
the translocation process when a YopK mutant expressed hypertranslocation (14).
Other Virulence Associated Factors: PNPase
Recently, it has been found that the exoribonuclease, polynucleotide
phosphorylase (PNPase) is required for the optimal function of the Yersiniae TTSS (29).
HeLa cells were used to examine the cytotoxic effect of Y. pseudotuberculosis and Y.
pestis pnp mutants by comparing mutant strain cytotoxicity to that of the wild-type
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strains. The kinetics of the HeLa cell cytotoxicity induced by pnp strains appeared
delayed, thereby indicating that the pnp strain had compromised TTSS activity (29).
More importantly, it was also shown that complementing the mutant strains with the S1
RNA-binding domain of PNPase could restore the optimal TTSS function. Furthermore,
a murine infection using the above mentioned strains recapitulated attenuated virulence in
the pnp strain (28).
Chaperones
Yops are translocated through a narrow hollow hole in the injectisome in an
unfolded state, suggesting that proteins may be secreted before acquiring their native
conformations (40). Some of these translocated or secreted proteins have been shown to
require small, usually acidic, accessory proteins with binding specificity towards each
individual secreted protein that maintains them in an unfolded conformation required for
passing through the needle (14, 40). These small chaperone proteins are required for
presecretory stabilization (14). The TTSS chaperones appear to keep secreted proteins
from prematurely interacting with translocatory proteins, fulfilling their role as
bodyguards (their second name) (14).
Chaperones have been described for the effector proteins YopE, YopT, and
YopH. SycE is the chaperone for YopE, SycT is the chaperone for YopT, and SycH is the
chaperon for YopH (34). SycD is the chaperone for both YopB and YopD (10, 24, 35),
while ScyN uses YscB (an injectisome protein) as a co-chaperone for secretion of YopN
in Y. pestis (35). Recently, two crystal structures of YopN in complex with its
heterodimeric secretion chaperone, SycN–YscB, and also the co-regulatory protein,
TyeA, were solved. These two structures were combined to construct a theoretical model
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of the YopN–SycN–YscB–TyeA complex (31). However, no chaperones had been
described for YopO, YopP, YopQ (YopK in Y. pseudotuberculosis), and YopM. More
recently, though, it was shown that these proteins did not require the assumed chaperones
(35).
Infection still a problem
Bubonic plague is a lethal disease caused by Yersinia pestis. The Japanese
weaponized Y. pestis from 1932 until the end of the Second World War when they used
Y. pestis-flea bombs on civilians and prisoners (27). Instead of using the flea as a vector,
some countries began to try aerosolizing Y. pestis. After 1969, the U.S. unilaterally
ceased in the production of biological weapons. Although not proven, it is believed that
the former Soviet Union created large facilities whose sole purposes were to find a way
to deliver Y. pestis strains by aerosol (27).
The U.S. national laboratory response network detects biological terrorism agents
such as Y. pestis. Once possible uses of biological weapons are found, they are referred to
the Center for Disease Control (CDC) and the American Society for Microbiology to
identify and confirm the Y. pestis strains (27). Streptomycin is traditionally regarded as
the most affective treatment for Y. pestis, 1g (twice daily) for ten days and was the first
antimicrobial shown to be affective against the pneumonic plague. Another drug that has
been found to be affective is aminoglycosidegentamycin. Although very rare, it has been
found that some strains of Y. pestis are antibiotic resistant, but luckily they have only
been reported in Madagascar (27). Unfortunately, the plasmid responsible for the
resistance has been reported to be self-transferrable to other bacteria (27).
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Vaccine Production
Killed-whole-cell vaccines and live-attenuated vaccines have been created in the
past, but have been found to be less than adequate. Not only do both vaccines only
provide a short duration of protective immunity, but also the killed-whole-cell vaccine
did not protect against primary pneumonic plague, while the live-attenuated vaccines
maintained enough virulence to be unsuitable and excessively dangerous for public use
(27). They offer low levels of protection, have numerous side effects, and require
frequent immunization (26).
As a result, researchers are looking towards subunit vaccines as the answer. LcrV
is an effecter protein translocated along with several Yops by the TTSS. This protein
suppresses the host’s immune system response. A subunit vaccine in development is
based on LcrV (also known as the (V) antigen). In a recent study, an adenovirus-based
vaccine vector expressing the V-antigen was used to immunize mice. The experimental
findings were that mice immunized with a single intramuscular dose of the vaccine were
protected from a lethal intranasal challenge of Y. pestis (26). Therefore, hope for an
effective mechanism whereby infection can be halted may be on the horizon.
Conclusion
There are three human pathogenic Yersiniae, which share a common virulence
factor termed the Type Three Secretion System present on an approximately 70-kb
virulence plasmid. Many other Gram-negative bacteria possess this system, which allows
them to transfer effector proteins directly into the host cell. The proteins that make up the
apparatus “injected” into the host cell termed the injectisome are homologous in all the
species that posses this system. However, the effector proteins are species-unique and are
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believed to have been acquired from the hosts each species infect. There is still a health
concern associated with Yersiniae especially with the plague-causing Y. pestis and its
ability to be aerosolized, making it a potential bioterrorist weapon. Understanding the
biology of the virulence factors of Yersiniae will allow for the development of novel
preventative and therapeutic strategies to cope with Yersiniae infections.
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